We have previously reported that ascorbic acid or a combination of asc
orbic acid and cupric sulfate was able to inhibit the growth of human
mammary and lung tumor xenografts in mice. In the present study, the 6
-day subrenal capsule assay method was used to investigate the effect
of ascorbic acid, cupric sulfate and ferric chloride on the growth of
a human colon tumor in mice, The method permits the observation of cha
nges in the size of tumor fragments implanted beneath the renal capsul
e of mice, without the effective intervention of the immune system. Re
sults of dose-response experiments indicate that tumor growth was inhi
bited when mice were fed a diet containing ascorbic acid (4 to 10 g/kg
body weight/day) in combination with cupric sulfate (2 to 4 mg/kg bod
y weight/day) or ferric chloride (2 to 8 mg/kg body weight/day), Ascor
bic acid alone was much less effective, Copper and iron alone enhanced
tumor growth. Since cupric or ferric ion is a catalyst for the oxidat
ion of ascorbic acid, the results support the suggestion that the anti
tumor mechanism involved a pro-oxidative effect of ascorbic acid on th
e tumor. The observed antitumor activity is not due to the metabolism
of ascorbic acid as a vitamin, but due to its chemical properties. The
tumor-inhibiting effect seems to be a direct growth suppressive actio
n of ascorbic acid oxidation and certain degradation products of ascor
bic acid, which are formed in vitro and are not formed by the metaboli
sm of ascorbic acid.